Table: OncoTherapy Science - 6-MTH group results

OncoTherapy Science

07/11/2025 08:00

Nov 7 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2025        Sep 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            431 mln             225 mln                    
                 (+91.9 pct)         (-36.9 pct)                  
  Operating     loss 475 mln        loss 531 mln                  
  Recurring     loss 493 mln        loss 545 mln                  
  Net           loss 555 mln        loss 545 mln                  
  EPS           loss 1.89 yen       loss 2.18 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T